Introductory Website

Initially approved by the FDA for the treatment of rheumatoid arthritis, this online introductory campaign reported the results of the new drug from three firsthand points of view: the patient, his wife and his doctor.

These stories detailed the restored mobility and freedom of the patient, his brighter outlook as seen by his wife, and the improved physical and mental conditions noted by his doctor.

I conducted the interviews and wrote the articles.